Madras Ent Research Foundation Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 9.00 M
as on 23-10-2024
- Company Age 23 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 15.02 Cr
as on 23-10-2024
- Revenue 54.39%
(FY 2023)
- Profit 448.92%
(FY 2023)
- Ebitda 1600.87%
(FY 2023)
- Net Worth 5.33%
(FY 2023)
- Total Assets 7.39%
(FY 2023)
About Madras Ent Research Foundation
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.00 M.
The company has closed loans amounting to ₹15.02 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Indira Kameswaran and Mohan Kameswaran serve as directors at the Company.
- CIN/LLPIN
U85110TN2001PTC047521
- Company No.
047521
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jul 2001
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Madras Ent Research Foundation?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Indira Kameswaran  | Director | 30-Jul-2001 | Current |
| Mohan Kameswaran | Director | 30-Jul-2001 | Current |
Financial Performance of Madras Ent Research Foundation.
Madras Ent Research Foundation Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 54.39% increase. The company also saw a substantial improvement in profitability, with a 448.92% increase in profit. The company's net worth moved up by a moderate rise of 5.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Madras Ent Research Foundation?
In 2023, Madras Ent Research Foundation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Indian Academy Of Otorhinolaryngology Head And Neck SurgeryActive 10 years 3 months
Mohan Kameswaran is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 18 Apr 2016 | ₹1.40 Cr | Satisfied |
Indian Bank Creation Date: 02 Dec 2013 | ₹5.25 Cr | Satisfied |
Indian Bank Creation Date: 02 Dec 2013 | ₹7.50 M | Satisfied |
How Many Employees Work at Madras Ent Research Foundation?
Madras Ent Research Foundation has a workforce of 16 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Madras Ent Research Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Madras Ent Research Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
